000 | 01104 a2200349 4500 | ||
---|---|---|---|
005 | 20250512032802.0 | ||
264 | 0 | _c19881128 | |
008 | 198811s 0 0 eng d | ||
022 | _a0362-5664 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCampbell, D B | |
245 | 0 | 0 |
_aFactors that may effect the reduction of hunger and body weight following d-fenfluramine administration. _h[electronic resource] |
260 |
_bClinical neuropharmacology _c1988 |
||
300 |
_aS160-72 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aEating _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFenfluramine _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHunger _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aWeight Loss _xdrug effects |
700 | 1 | _aGordon, B H | |
700 | 1 | _aIngs, R M | |
700 | 1 | _aRichards, R | |
700 | 1 | _aTaylor, D W | |
773 | 0 |
_tClinical neuropharmacology _gvol. 11 Suppl 1 _gp. S160-72 |
|
999 |
_c3058626 _d3058626 |